Lantern Pharma Inc Financial Flexibility Index
Lantern Pharma Inc financial flexibility index. Lantern Pharma Inc (LTRN) has a Financial Flexibility Index of -0.25x as of June 2026. Free cash flow of $-2.94 Million (operating CF $-2.94 Million minus capex $0.00) represents 0% of total liabilities ($11.82 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lantern Pharma Inc (2018–2025)
Financial flexibility index of Lantern Pharma Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Lantern Pharma Inc across 8 annual periods. Explore Lantern Pharma Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Lantern Pharma Inc Financial Flexibility Index by Year (2018–2025)
Lantern Pharma Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Lantern Pharma Inc. For the full cash flow conversion analysis, see Lantern Pharma Inc (LTRN) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.48x | $-15.68 Million | $-15.68 Million | $4.50 Million | ▲ +14.2% |
| 2024 | -4.06x | $-17.80 Million | $-17.81 Million | $4.38 Million | ▲ +22.4% |
| 2023 | -5.23x | $-14.33 Million | $-14.35 Million | $2.74 Million | ▼ -14.9% |
| 2022 | -4.55x | $-12.74 Million | $-12.77 Million | $2.80 Million | ▼ -2.4% |
| 2021 | -4.45x | $-10.58 Million | $-10.59 Million | $2.38 Million | ▲ +47.9% |
| 2020 | -8.53x | $-5.64 Million | $-5.65 Million | $660.84K | ▼ -96.6% |
| 2019 | -4.34x | $-2.12 Million | $-2.13 Million | $489.29K | ▼ -123.3% |
| 2018 | -1.94x | $-1.27 Million | $-1.27 Million | $651.63K | — |